Cargando…
Vaccine effectiveness of the pneumococcal polysaccharide and conjugated vaccines in elderly and high-risk populations in preventing invasive pneumococcal disease: a systematic search and meta-analysis
Background: Invasive pneumococcal disease (IPD) is a major cause of morbidity and mortality globally. However, the literature on the vaccine effectiveness (VE) of 23-valent polysaccharide vaccine (PPV23) and 13-valent conjugated vaccine (PCV13) against IPD in adults is sparse. The aim was to summari...
Autores principales: | Sikjær, Melina Gade, Pedersen, Andreas Arnholdt, Wik, Mari Stenvold, Stensholt, Synne Smith, Hilberg, Ole, Løkke, Anders |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9870017/ https://www.ncbi.nlm.nih.gov/pubmed/36698750 http://dx.doi.org/10.1080/20018525.2023.2168354 |
Ejemplares similares
-
Parental COPD as a Risk Factor for the Development of COPD and Disease Severity in Offspring: A Systematic Scoping Review
por: Sikjær, Melina Gade, et al.
Publicado: (2022) -
Polysaccharide Responsiveness Is Not Biased by Prior Pneumococcal-Conjugate Vaccination
por: Bernth-Jensen, Jens Magnus, et al.
Publicado: (2013) -
Pneumococcal vaccination in persons living with HIV: Pneumococcal conjugate, polysaccharide or both?
por: Dhingra, Bhavna, et al.
Publicado: (2020) -
Pneumococcal Conjugate Vaccination Followed by Pneumococcal Polysaccharide Vaccination in Lung Transplant Candidates and Recipients
por: Hoffman, Thijs W., et al.
Publicado: (2020) -
Pneumococcal vaccination of older adults: Conjugate or polysaccharide?
por: Hollingsworth, Rosalind, et al.
Publicado: (2014)